Incyte Corp (NASDAQ: INCY) is 1.07% higher on its value in year-to-date trading and has touched a low of $50.35 and a high of $83.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INCY stock was last observed hovering at around $69.68 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $69.81, the stock is -2.53% and -2.50% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.31 million and changing 0.19% at the moment leaves the stock 3.75% off its SMA200. INCY registered 18.22% gain for a year compared to 6-month gain of 6.32%.
The stock witnessed a -5.33% loss in the last 1 month and extending the period to 3 months gives it a -6.41%, and is -6.04% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.80% over the week and 3.35% over the month.
Incyte Corp (INCY) has around 2617 employees, a market worth around $13.51B and $4.24B in sales. Current P/E ratio is 257.41 and Fwd P/E is 10.95. Profit margin for the company is 0.77%. Distance from 52-week low is 38.65% and -16.84% from its 52-week high. The company has generated returns on investments over the last 12 months (0.93%).
The EPS is expected to grow by 422.91% this year
The shares outstanding are 193.43M, and float is at 190.70M with Short Float at 4.36%.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 30.74 million shares valued at $1.86 billion. The investor’s holdings represent 14.0889 of the INCY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 21.36 million shares valued at $1.29 billion to account for 9.5135 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 20.38 million shares representing 9.0766 and valued at over $1.24 billion, while DODGE & COX holds 7.0033 of the shares totaling 15.28 million with a market value of $926.23 million.
Incyte Corp (INCY) Insider Activity
A total of 0 insider transactions have happened at Incyte Corp (INCY) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Incyte Corp disclosed in a document filed with the SEC on Feb 26 ’25 that Denton Sheila A. (EVP & General Counsel) sold a total of 14,069 shares of the company’s common stock. The trade occurred on Feb 26 ’25 and was made at $74.07 per share for $1.04 million. Following the transaction, the insider now directly holds 25848.0 shares of the INCY stock.
Still, SEC filings show that on Feb 26 ’25, SHEILA DENTON (Officer) Proposed Sale 14,069 shares at an average price of $74.07 for $1.04 million. The insider now directly holds shares of Incyte Corp (INCY).
Incyte Corp (INCY): Who are the competitors?
One of the company’s main competitors (and peers) include Alnylam Pharmaceuticals Inc. (ALNY) that is trading 66.53% up over the past 12 months.Novonesis A/S Series B (NSIS.B) lies in the list of competitors of the Incyte Corp and is 7.86% higher over the same period from INCYBio-Techne Corp. (TECH) is -16.71% down on the 1-year trading charts.
